Syros Pharmaceuticals, Inc. (0S9.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:06AM CEST. Market open.
| Previous Close | 0.6700 |
| Open | 0.6570 |
| Bid | 0.6856 x 0 |
| Ask | 0.6880 x 0 |
| Day's Range | 0.6570 - 0.6570 |
| 52 Week Range | 0.6570 - 5.8500 |
| Volume | |
| Avg. Volume | 169 |
| Market Cap | 40.699M |
| Beta (5Y Monthly) | 2.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3930 |
| Earnings Date | Mar 02, 2022 - Mar 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.14 |
- Zacks
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 16.67% and 20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update
CAMBRIDGE, Mass., May 16, 2022--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended March 31, 2022 and provided a corporate update.
- Zacks
Strength Seen in Immatics (IMTX): Can Its 5.3% Jump Turn into More Strength?
Immatics (IMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2022 Yahoo. All rights reserved.
